FGC
IRD

Financial Gravity Companies’s Opus Genetics IRD Stock Holding History

Financial Gravity Companies’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$15.6K Buy
+16,555
New +$15.3K ﹤0.01% 499
2024
Q4 		$19.7K Buy
+16,555
New +$19K ﹤0.01% 447

Other funds holding IRD

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Financial Gravity Companies's IRD Position: Q2 2025 in Review

Financial Gravity Companies opened a new position in Opus Genetics (IRD) in Q2 2025: 16,555 shares worth $15.6K. The stake represents ﹤0.01% of the portfolio and ranks #499 among its holdings. This is a return to the name: Financial Gravity Companies previously reported a position in IRD as recently as Q4 2024.

Financial Gravity Companies first reported a position in IRD in Q4 2024 and has held it in 2 quarters since. The position peaked at $19.7K in Q4 2024. 43 funds tracked by Wall St. Rank hold IRD as of Q2 2025.

  • Financial Gravity Companies held 16,555 shares of Opus Genetics worth $15.6K as of Q2 2025.
  • Opus Genetics was a new Financial Gravity Companies position in Q2 2025.
  • Opus Genetics made up ﹤0.01% of Financial Gravity Companies's portfolio in Q2 2025, its #499 holding.
  • Financial Gravity Companies first reported a position in Opus Genetics in Q4 2024 and has held it in 2 quarters since.
  • Financial Gravity Companies's Opus Genetics position peaked at $19.7K in Q4 2024.
  • 43 funds tracked by Wall St. Rank held Opus Genetics as of Q2 2025.

Based on Financial Gravity Companies's 13F filing for Q2 2025, filed 8 Aug 2025.